Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
09 févr. 2024 06h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month...
embecta Announces Quarterly Cash Dividend
09 févr. 2024 06h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
embecta to Participate in the 11th Annual BTIG MedTech Conference
07 févr. 2024 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will host one-on-one investor meetings on Tuesday, February 13, 2024, at...
embecta to Report Fiscal First Quarter 2024 Financial Results
24 janv. 2024 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
09 janv. 2024 06h00 HE
|
Embecta Corp.
embecta has submitted a 510(k) premarket filing to the FDA for a proprietary disposable insulin delivery system.
embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
14 déc. 2023 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on...
No embecta-made syringes impacted by FDA safety communication
01 déc. 2023 06h00 HE
|
Embecta Corp.
Embecta Corp. issued a statement regarding the FDA's safety communication on evaluation of certain plastic syringes
embecta to Participate in Investor Conferences
29 nov. 2023 17h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following...
Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance
21 nov. 2023 05h30 HE
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and...
embecta Announces Quarterly Cash Dividend
21 nov. 2023 05h00 HE
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...